On ECHEMI
Home > Drugs > Trimethoprim Tablets

Trimethoprim Tablets

Function and Efficacy

Not yet clear.

Ingredients

The content of trimetazidine hydrochloride (C14H22N2O3·2HCl) in this product should be 90.0% to 110.0% of the labeled amount.

Appearance

This product is white tablets.

Indication

It is suitable for coronary insufficiency, angina pectoris, and old myocardial infarction. It can be used together with digitalis for patients with severe heart failure.

Usage and Dosage

1. Oral: 2-6 mg each time, 3 times a day, after meals: total daily dose not exceeding 18 mg. The commonly used maintenance dose is 1 mg each time, 3 times a day. 2. Intramuscular injection: 4-8 mg, 1-2 times a day.

Adverse Reactions

Nausea and vomiting are rare, and some patients may experience dizziness, loss of appetite, rash, etc. [Foreign adverse reactions reference] 1. Cardiovascular system There are case reports that the use of this drug before aortic-coronary artery bypass grafting can cause a slight increase in mean arterial pressure; there are also reports that this drug causes the condition of patients with exertional angina pectoris and hypertension to worsen. 2. Gastrointestinal tract Oral administration of this drug may cause stomach burning or other symptoms of gastrointestinal dysfunction.

Precautions

(1) Those who are allergic to this drug. (2) Those who have recently suffered a myocardial infarction. (3) Pregnant women. (4) Breastfeeding women.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not for use by pregnant and lactating women. Precautions for the elderly: Not yet clear.

Drug Interactions

(1) There is still a lack of pharmacokinetic studies on patients with impaired liver and kidney function. Such patients should be cautious when using this drug. (2) Unstable angina. (3) Hypertension. (All the above are selected from foreign data)

Storage

Keep sealed.

Packaging Specification

3mg

Validity Period

24 months

Manufacturer

China Resources Zizhu Pharmaceutical Co., Ltd.

  • Founded in:

    1980-11-26
  • Address:

    Building 18, No. 27 Chaoyang North Road, Chaoyang District, Beijing
  • Tax NO.:

    91110000101939631P
  • Registered Funds:

    660.6396 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.